ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) | Grant Type |
Year |
State |
|---|---|---|---|---|
| Synthetic gene expression regulator switches (SynGERS) expressed in CAR T cells to cure children with solid tumors | Baylor College of Medicine / Andras Heczey, MD | R Accelerated Award Grants | 2023 | Texas |
| CLL-1 CAR-T cells with or without trametinib for the treatment of JMML | The Regents of the University of California San Francisco / Elliot Stieglitz, MD | R Accelerated Award Grants | 2023 | California |
| Activation of Anti-Leukemia Immunity by Targeting Protein Arginine Methyltransferase | City of Hope National Medical Center / Ling Li, PhD | R Accelerated Award Grants | 2023 | California |
| Targeting the biological underpinnings of pulmonary metastasis in osteosarcoma | Dana-Farber Cancer Institute / Rani George, MD/PhD | Crazy 8 Awards | 2022 | Massachusetts |
| GENOME ORIGAMI: Refolding Aberrant Chromosome 3D Structure for Treating NUT Carcinoma | Baylor College of Medicine / Kyle Eagen, PhD | R Accelerated Award Grants | 2022 | Texas |
| Targeting Kinase Inhibitor Induced DNA-Damage Response in Ph-Like ALL | Temple University / Christian Hurtz, PhD | 'A' Award Grants | 2022 | Pennsylvania |
| Novel Therapy for Pediatric Leukemia Patients with NUP98 Translocations | The Regents of the University of Michigan / Jolanta Grembecka, PhD | Reach Grants | 2022 | Michigan |
| Inhibition of translation initiation as a novel therapeutic strategy against MYCN-amplified neuroblastoma | Dana-Farber Cancer Institute / Rani George, MD, PhD | Innovation Grants | 2022 | Massachusetts |
| Epigenetic Enhancement of MHCI to Augment Neuroblastoma Immunotherapy | University of Wisconsin - Madison / Paul Sondel, MD, PhD and Amy Erbe-Gurel, PhD | Innovation Grants | 2022 | Wisconsin |
| Blocking the Evil Messenger in MYCN-driven High-risk Neuroblastoma | Boston University / Hui Feng, Md, PhD | Innovation Grants | 2022 | Massachusetts |